Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CUCUMBER

Financiado

Cerrado

Bringing to market the world s first integrated medical cooling system for minim...

Bringing to market the world s first integrated medical cooling system for minimizing brain damage in stroke patients. Stroke-related disabilities remains a major challenge faced by patients, their families and healthcare systems worldwide and is estimated to cost healthcare systems over €45B/year. In Europe, there are over 1.1M new incidences of... ver más

31/05/2025

UKLFR

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

UNIVERSITAETSKLINIKUM FREIBURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-11-09

EIC-FTI-2018-2020: Fast Track to Innovation (FTI)

I+D

Cerrada hace 6 años

0% 78% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

UKLFR

936.88K€ | Lider

TEAM AND CLOUD

TELNET REDES INTELIGENTES

178.95K€ | Participante

INFAI

79.69K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUROHYP-1 European multicentre randomised phase III clinical trial o... 12M€ Cerrado

ARISE Affording Recovery In Stroke 16M€ Cerrado

SAF2011-30517 INDUCCION DE HIPOTERMIA CEREBRAL FOCAL MEDIANTE NANOMATERIAL... 194K€ Cerrado

promise BraiN20®: A paradigm shift in Acute Ischemic Stroke (AIS) pa... 5M€ Cerrado

TIN2012-38450-C03-01 ANALISIS MULTIPARAMETRICO DE IMAGEN, CLINICA Y TERAPIA PARA... 129K€ Cerrado

SOPRANI European training network for developing Smart neurOmonitori... Cerrado

Duración del proyecto: 54 meses Fecha Inicio: 2020-11-09
Fecha Fin: 2025-05-31

Líder del proyecto

UNIVERSITAETSKLINIKUM FREIBURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Stroke-related disabilities remains a major challenge faced by patients, their families and healthcare systems worldwide and is estimated to cost healthcare systems over €45B/year. In Europe, there are over 1.1M new incidences of stroke per year, a third of which will result in permanent disabilities such as limited mobility and affected cognitive function. These handicaps are a result of the brain damage caused by blocked blood flow to the brain, as well as further damage following the recanalization of an arterial blockage. Targeted temperature management (TTM), also known as 'brain cooling', is a method that has proven effective in reducing brain injury in sudden cardiac arrest patients. Extrapolation of TTM to stroke will have a tremendous impact on patient outcomes, however, the limited functionalities of current cooling technologies prevent this realization. The CUCUMBER consortium, whose expertise range from engineering, manufacturing, clinical neurology and stroke, are working to change this paradigm by developing CoolConnect, the world's first cooling device that accommodates the needs of stroke treatment to improve patient’s outcome, survival, and neurological outcome. CoolConnect is an integrated device composed of 3 components (RhinoChill, BrainCool, and BrainTemp sensor), which come together to address the 3 critical phases of brain cooling, 1)Early cooling, 2)Cooling during reperfusion and 3)maintenance cooling. CoolConnect is the only solution in development designed for this purpose. FTI grant is requested to fast-track the market launch of CoolConnect by 2024, to ensure broad and sustainable uptake in the following years. Our main aim is to validate CoolConnect in a large, multicenter trial, and to implement all market access and communication activities critical for broad market adoption. There are >288,000 eligible patients for CoolCoonect per year in EU/US, and yearly revenues of €56M can be anticipated following 5 years of commercialization.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores